These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23743438)

  • 1. Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis.
    Wan KH; Chen LJ; Rong SS; Pang CP; Young AL
    Ophthalmology; 2013 Nov; 120(11):2197-203. PubMed ID: 23743438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data.
    Swamy BN; Chilov M; McClellan K; Petsoglou C
    Ophthalmic Epidemiol; 2007; 14(5):311-9. PubMed ID: 17994441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cyclosporine for atopic keratoconjunctivitis.
    González-López JJ; López-Alcalde J; Morcillo Laiz R; Fernández Buenaga R; Rebolleda Fernández G
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009078. PubMed ID: 22972132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
    Ozcan AA; Ersoz TR; Dulger E
    Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A; Gürler B
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
    Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
    Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis.
    Wan XC; Dimov V
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):543-9. PubMed ID: 24490943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.
    Daniell M; Constantinou M; Vu HT; Taylor HR
    Br J Ophthalmol; 2006 Apr; 90(4):461-4. PubMed ID: 16547328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis.
    Zhou XQ; Wei RL
    Cornea; 2014 Jul; 33(7):760-7. PubMed ID: 24815112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loteprednol etabonate in the treatment of allergic conjunctivitis: a meta-analysis.
    Wu LQ; Chen X; Lou H; Cheng JW; Wei RL
    Curr Med Res Opin; 2015 Aug; 31(8):1509-18. PubMed ID: 26039179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective review on the use of topical cyclosporin a 0.05% for paediatric allergic conjunctivitis in Hong Kong Chinese.
    Wu MM; Yau GS; Lee JW; Wong AL; Tam VT; Yuen CY
    ScientificWorldJournal; 2014; 2014():396987. PubMed ID: 25386595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis.
    Wan KH; Chen LJ; Young AL
    Ocul Surf; 2015 Jul; 13(3):213-25. PubMed ID: 26045239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.
    Kam KW; Chen LJ; Wat N; Young AL
    Ocul Immunol Inflamm; 2017 Oct; 25(5):663-677. PubMed ID: 27192186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.